AstraZeneca to buy medicines for rare diseases
AstraZeneca invests $1 billion in Pfizer's catalog for orphan drugs; warn about the risk of blindness caused by diabetic retinopathy, and Colombia launches an AstraZeneca has invested $1 billion in Pfizer's catalog for orphan drugs, and Colombia has launched an innovative mobility program for people with disabilities. The deal should close before the end of the third quarter of 2023 and diabetes is estimated to be the leading cause of blindness in the world. The State Department is proud of the 33rd anniversary of the Americans with Disabilities Act, and the ADA continues to inspire countries and communities around the world to ensure equal rights and opportunities. A pilot project has been launched to improve the mobility of people with disabled people using electric motors, with the aim of converting them into electric bikes.
ที่ตีพิมพ์ : 2 ปีที่แล้ว โดย TGS ใน Health
AstraZeneca invests $1 billion in Pfizer’s catalog for orphan drugs; warn about the risk of blindness caused by diabetic retinopathy, and Colombia launches an innovative mobility program for people with disabilities, among the hottest news of the day on disability.
British pharmaceutical giant will pay Pfizer at least $1 billion for this catalog of drugs designed to treat more than 7,000 identified rare diseases, 80 percent of which are believed to be caused by genetic mutations. The deal, which was announced as part of AstraZeneca’s preliminary earnings report, should close before the end of the third quarter of 2023.
Diabetic retinopathy is the leading cause of blindness in the world and it is estimated that more than 30 percent of people with diabetes in Mexico have an eye disease, leading to a high risk of blindness. Dr. Josafat Eleazar Camacho Arellano, Medical President of the Mexican Diabetes Federation (FMD), stressed that diabetes is a pandemic that affects 529 million people worldwide and that this number will double by 2050. In turn, Dr. Francisco Martinez Castro, director for Latin America of the International Agency for the Prevention of Blindness, warned that both diabetic retinopathy and glaucoma are irreversible, so it is important to detect them in time to avoid blindness.
Through the social program at Papagayo Park, they aim to integrate children with autism.
As part of a social program in Papagayo Park, members of the civic association “Parents United Against Autism in Guerrero” are trying to reintegrate girls, boys and young people diagnosed with autism spectrum disorder into civil society. Roberto Basilio Nava, president of the civic association, said that the life situation of people with autism is complicated by the fact that they are subjected to abuse, discrimination and bullying. “Unfortunately in Guerrero and across the country there are no statistics on the actual number of people living with autism and that is because we don’t have trained staff to provide good care, there is a lot of neglect and interest from our politicians and governments to look for action. that serve to improve people’s living conditions,” he said.
Through the Sun of Acapulco
The State Department is proud of the 33rd anniversary of the Americans with Disabilities Act (ADA). The agency noted that more than three decades after the passage of this groundbreaking law, the ADA continues to inspire countries and communities around the world to ensure equal rights and opportunities for people with disabilities. “Today and every day in our foreign policy work, we place particular emphasis on the international community of people with disabilities whose skills and contributions bring innovation, diversity and value to their societies, communities and families.”
Pilot project launched to improve the mobility of people with disabilities
Despacio and Tembici, operator of the Bogota Shared Bicycle (SBC) system, announce the start of a pilot project that aims to include electric motors in the manocletas (hand bikes) available in the system, with the aim of converting them into electric bikes. assistance for people with disabilities or reduced mobility, who would be able to move more easily. The six-month pilot test will take place between July and December 2023 and will consist of electrifying a portion of the 150-manoclet existing in the Colombian capital.
หัวข้อ: AstraZeneca